Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Effect of lesion of cortical dopamine terminals on subcortical dopamine receptors in rats.

× No keyword cloud information.

66 in total

1. Increased baseline occupancy of D2 receptors by dopamine in schizophrenia.

Authors: A Abi-Dargham; J Rodenhiser; D Printz; Y Zea-Ponce; R Gil; L S Kegeles; R Weiss; T B Cooper; J J Mann; R L Van Heertum; J M Gorman; M Laruelle
Journal: Proc Natl Acad Sci U S A Date: 2000-07-05 Impact factor: 11.205

Review 2. Animal models of schizophrenia: a critical review.

Authors: E R Marcotte; D M Pearson; L K Srivastava
Journal: J Psychiatry Neurosci Date: 2001-11 Impact factor: 6.186

3. MDMA administration during adolescence exacerbates MPTP-induced cognitive impairment and neuroinflammation in the hippocampus and prefrontal cortex.

Authors: Giulia Costa; Nicola Simola; Micaela Morelli
Journal: Psychopharmacology (Berl) Date: 2014-04-01 Impact factor: 4.530

Review 4. Antipsychotic and antidepressive effects of second generation antipsychotics: two different pharmacological mechanisms?

Authors: Hans-Jürgen Möller
Journal: Eur Arch Psychiatry Clin Neurosci Date: 2005-06 Impact factor: 5.270

5. Changes in levels of D1, D2, or NMDA receptors during withdrawal from brief or extended daily access to IV cocaine.

Authors: Osnat Ben-Shahar; Patrick Keeley; Mariana Cook; Wayne Brake; Megan Joyce; Myriel Nyffeler; Rebecca Heston; Aaron Ettenberg
Journal: Brain Res Date: 2006-12-11 Impact factor: 3.252

6. Modulation of nicotine effects on selective attention by DRD2 and CHRNA4 gene polymorphisms.

Authors: Stefan Ahrens; Sebastian Markett; Thomas P K Breckel; Oliver Behler; Martin Reuter; Christiane M Thiel
Journal: Psychopharmacology (Berl) Date: 2015-02-03 Impact factor: 4.530

7. Enhanced frontal function in Parkinson's disease.

Authors: R Cools; A Miyakawa; M Sheridan; M D'Esposito
Journal: Brain Date: 2009-12-07 Impact factor: 13.501

Review 8. Effects of chronic neuroleptic treatment on dopamine release: insights from studies using 3-methoxytyramine.

Authors: M F Egan; S Chrapusta; F Karoum; B K Lipska; R J Wyatt
Journal: J Neural Transm (Vienna) Date: 1996 Impact factor: 3.575

9. Individual differences in frontal cortical thickness correlate with the d-amphetamine-induced striatal dopamine response in humans.

Authors: Kevin F Casey; Mariya V Cherkasova; Kevin Larcher; Alan C Evans; Glen B Baker; Alain Dagher; Chawki Benkelfat; Marco Leyton
Journal: J Neurosci Date: 2013-09-18 Impact factor: 6.167

10. Genetic Disruption of Arc/Arg3.1 in Mice Causes Alterations in Dopamine and Neurobehavioral Phenotypes Related to Schizophrenia.

Authors: Francesca Managò; Maddalena Mereu; Surjeet Mastwal; Rosa Mastrogiacomo; Diego Scheggia; Marco Emanuele; Maria A De Luca; Daniel R Weinberger; Kuan Hong Wang; Francesco Papaleo
Journal: Cell Rep Date: 2016-08-11 Impact factor: 9.423